Close

Analyst Ratings for Biohaven Pharmaceutical Holding (BHVN)

BHVN Rating Summary

BHVN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BHVN
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $59.63 (+41.4%) * Over Last 12-Mos
Rating Score: 7.8 / 10   Percentile Rank: 82%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/16/2024 RBC Capital
» Updated 3/1/2024
Leonid Timashev New Coverage Outperform
(N/A)
61.00
(62.00)
49.11
(42.16)
-14.15% Details
2/6/2024 UBS Ashwani Verma New Coverage Buy
(N/A)
59.00
(N/A)
44.79
(42.16)
-5.87% Details